{"text_format":"3","workbook":"xlsx","n_sheets":2,"sheets":["Supplemental Table 1","Supplemental Table 2"],"not_rendered":{"defined_names":1},"read":"whole","date_system":"1900"}

{"sheet":"Supplemental Table 1","index":0,"n_rows":8,"n_cols":16,"rows_kept":8,"merged":[[1,1,1,7],[1,9,1,14],[2,1,2,3],[2,5,2,7],[2,9,2,11],[2,12,2,14]]}
["Supplemental Table 1"]
[null,"Plasma glucose (mg/dl)",{"$nulls":7},"Plasma insulin (ng/ml)"]
[null,"Fasting",{"$nulls":3},"Feeding",{"$nulls":3},"Fasting",null,null,"Feeding"]
["15PAA",127.2,"±",6.5,"a",202.1,"±",7.6,null,0.34,"±",{"v":0.1,"d":"0.10"},3.22,"±",0.22,"ab"]
["5PAA",141.7,"±",6.3,"ab",195.7,"±",9.2,null,0.57,"±",0.23,1.94,"±",0.38,"a"]
["Low Arg",156.3,"±",3.6,"b",208.6,"±",8.9,null,0.58,"±",{"v":0.1,"d":"0.10"},4.58,"±",0.63,"b"]
["Data are shown as the mean +/- S.E.M. "]
["Different superscript letters denote significant differences (p<0.05)"]

{"sheet":"Supplemental Table 2","index":1,"n_rows":30,"n_cols":8,"rows_kept":30,"merged":[[1,0,2,0],[1,1,2,1],[1,2,1,4],[1,5,1,6],[1,7,2,7],[29,0,29,7]]}
["Supplemental Table 2 List of apolipoprotein genes"]
["Gene symbol","Gene titile","Signal",null,null,"Fold change",null,"Probe set ID"]
[null,null," 15PAA","5PAA","Low Arg","5PAA     vs. 15PAA","Low Arg vs. 15PAA"]
["Apoa1","apolipoprotein A-I",5672.8,4201.6,3789.2,{"v":0.8122523963562355,"d":"0.81"},{"v":0.5743491774985175,"d":"0.57"},"1368335_at"]
["Apoa1bp","apolipoprotein A-I binding protein",424.5,410.6,604.9,{"v":1,"d":"1.00"},{"v":1,"d":"1.00"},"1367520_at"]
["Apoa2","apolipoprotein A-II",8921.6,6917.8,9173.8,{"v":0.8122523963562355,"d":"0.81"},{"v":0.8122523963562355,"d":"0.81"},"1369727_at"]
["Apoa4","apolipoprotein A-IV",1612.7,1904.1,933.8,{"v":1.148698354997035,"d":"1.15"},{"v":0.4665164957684037,"d":"0.47"},"1368520_at"]
["Apoa5","apolipoprotein A-V",1617.3,1078.5,1861.5,{"v":0.7071067811865475,"d":"0.71"},{"v":0.8705505632961241,"d":"0.87"},"1369011_at"]
["Apob","apolipoprotein B",9661.4,8799,9768.9,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1388190_at"]
["Apob","apolipoprotein B",45.5,47.2,42.2,{"v":1.0717734625362931,"d":"1.07"},{"v":0.6155722066724582,"d":"0.62"},"1371157_at"]
["Apobec1","apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1",74.3,72.4,44.1,{"v":0.9330329915368074,"d":"0.93"},{"v":0.5,"d":"0.50"},"1368270_at"]
["Apobec2","apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2",5.6,4.8,17.6,{"v":1.2311444133449163,"d":"1.23"},{"v":2,"d":"2.00"},"1371492_at"]
["Apobec3b","apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B",1.3,1.5,0.6,{"v":0.6597539553864472,"d":"0.66"},{"v":0.8705505632961241,"d":"0.87"},"1392810_at"]
["Apobr","apolipoprotein B receptor",2.6,2.8,2.6,{"v":2.63901582154579,"d":"2.64"},{"v":0.8705505632961241,"d":"0.87"},"1384929_at"]
["Apoc1","apolipoprotein C-I",8666.2,7744.3,8989.6,{"v":0.8705505632961241,"d":"0.87"},{"v":0.8122523963562355,"d":"0.81"},"1368587_at"]
["Apoc2","apolipoprotein C-II",6828.2,5860,6853.1,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1393139_at"]
["Apoc3","apolipoprotein C-III",10776.9,10266.7,10653.8,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1370009_at"]
["Apoc4","apolipoprotein C-IV",2265.8,2022.8,3322.7,{"v":0.9330329915368074,"d":"0.93"},{"v":1.148698354997035,"d":"1.15"},"1384417_at"]
["Apod","apolipoprotein D",9.8,6,13.1,{"v":0.6597539553864472,"d":"0.66"},{"v":0.8705505632961241,"d":"0.87"},"1398258_at"]
["Apoe","apolipoprotein E",7098.4,6911.9,6992.2,{"v":0.9330329915368074,"d":"0.93"},{"v":0.7578582832551991,"d":"0.76"},"1370862_at"]
["Apoh","apolipoprotein H (beta-2-glycoprotein I)",8351.4,8174.6,8295.6,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1389350_at"]
["Apol9a","apolipoprotein L 9a",91.7,77.7,106.5,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1376496_at"]
["Apol3","apolipoprotein L, 3",84.1,92.6,104.5,{"v":0.9330329915368074,"d":"0.93"},{"v":0.8122523963562355,"d":"0.81"},"1379604_at"]
["LOC100910885","apolipoprotein L3-like",357.6,234.5,348.9,{"v":0.7071067811865475,"d":"0.71"},{"v":0.8122523963562355,"d":"0.81"},"1372604_at"]
["Apom","apolipoprotein M",2275.3,1634.3,2960.2,{"v":0.7071067811865475,"d":"0.71"},{"v":0.9330329915368074,"d":"0.93"},"1386980_at"]
["Apon","apolipoprotein N",1124.1,880.8,1538.6,{"v":0.8122523963562355,"d":"0.81"},{"v":1.0717734625362931,"d":"1.07"},"1393826_at"]
["Apoo","apolipoprotein O",190.5,278.7,198.3,{"v":1.4142135623730951,"d":"1.41"},{"v":0.8705505632961241,"d":"0.87"},"1375297_at"]
["Apool","apolipoprotein O-like",277.3,348.9,254.8,{"v":1.2311444133449163,"d":"1.23"},{"v":0.7578582832551991,"d":"0.76"},"1389148_at"]
[]
["DNA Microarray analysis\nDNA microarray was performed on total RNA samples (250 ng) generated by pooling equal amounts of hepatic RNA from rats in the same group. Amplified antisense RNA synthesis, purification, and fragmentation were performed according to the footnote to Supplementary Table 2. The amplified antisense RNA was hybridized in hybridization cocktail to a GeneChip® Rat Genome 230 2.0 Array (Affymetrix, Santa Clara, CA, USA) for 16 h at 45°C. The chip was then washed and stained using the GeneChip® Fluidics Station 400 (Affymetrix). Signal intensity was analyzed by Affymetrix GeneChip® Command Console Software. The changes in the expression of each probe are displayed as a signal log ratio. \n\n"]